自闭症
医学
干细胞
干细胞疗法
免疫失调
生物信息学
免疫系统
免疫学
移植
精神科
内科学
生物
遗传学
作者
Francesca Pistollato,Tamara Yuliett Forbes-Hernández,Rubén Calderón Iglesias,Roberto Ruíz,María Elexpuru-Zabaleta,Danila Cianciosi,Francesca Giampieri,Maurizio Antonio Battino
标识
DOI:10.1016/j.phrs.2019.104579
摘要
In the last decade, the prevalence of autism spectrum disorders (ASD) has dramatically escalated worldwide. Currently available drugs mainly target some co-occurring symptoms of ASD, but are not effective on the core symptoms, namely impairments in communication and social interaction, and the presence of restricted and repetitive behaviors. On the other hand, transplantation of hematopoietic and mesenchymal stem cells in ASD children has been shown promising to stimulate the recruitment, proliferation, and differentiation of tissue-residing native stem cells, reducing inflammation, and improving some ASD symptoms. Moreover, several comorbidities have also been associated with ASD, such as immune dysregulation, gastrointestinal issues and gut microbiota dysbiosis. Non-pharmacological approaches, such as dietary supplementations with certain vitamins, omega-3 polyunsaturated fatty acids, probiotics, some phytochemicals (e.g., luteolin and sulforaphane), or overall diet interventions (e.g., gluten free and casein free diets) have been considered for the reduction of such comorbidities and the management of ASD. Here, interventional studies describing pharmacological and non-pharmacological treatments in ASD children and adolescents, along with stem cell-based therapies, are reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI